If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 6.00 (5.882%)
Open: 105.00
High: 105.00
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing

16 May 2007 07:01

Intercede Group PLC16 May 2007 16 MAY 2007 Intercede Group plc ("Intercede" or "Company") Placing to raise £0.7 million Intercede, one of the world's leading developers and suppliers of smart card andidentity management software, is pleased to announce today the conditionalplacing of 2,130,303 new Ordinary Shares of 1 pence each at a price of 33 penceper new Ordinary Share with institutional and other investors to raiseapproximately £0.7 million (approximately £0.7 million after expenses). Over the past year, Intercede has made excellent progress in establishing itsMyID product as the software of choice in the US Government's programme ofissuing new identity cards to all federal employees and contractors. The newfunds are intended to facilitate the further exploitation of this opportunity,as well as providing general working capital in advance of longer term revenuestreams accruing to the Company as a result of the contracts that it has alreadywon. The Board considers that the raising of further equity capital by means of aplacing was acceptable having due regard for the time and cost considerations ofraising money through pre-emptive mechanisms. On 27 March 2007, Intercede reported that it expected revenues for the full yearended 31 March 2007 to be no less than 20% ahead of the previous financial year.The Board expects to confirm this when the Company's preliminary results areannounced, which will take place within the next two weeks. Interest inIntercede's MyID product remains strong and the Company's prospects are thusencouraging. The placing is conditional on admission of the new Ordinary Shares to AIM ("Admission"), though is not conditional on the prior approval of shareholders.The placing has been conducted using authorities approved at the Company's lastAGM held on 5 July 2006. Application will be made to London Stock Exchange for the placing shares to beadmitted to trading on AIM and it is anticipated that dealings in the placingshares will commence on 22 May 2007. The placing shares have been issuedcredited as fully paid and will rank pari passu in all respects with theexisting Ordinary Shares in the Company, including the right to receive alldividends and other distributions declared or paid thereon following Admission.The placing shares will represent approximately 5.9 per cent. of the enlargedissued ordinary share capital of the Company immediately following Admission. Richard Parris, Chief Executive Officer, commented: "We are pleased to have secured new institutional backing for the Group. This isthe first time that Intercede has raised funds since July 2003. The cash raisedwill provide additional working capital and will also enable the Group toexploit more fully the various opportunities around the world that areincreasingly presenting themselves. The opportunity in the United States is themost immediate, a situation that we have anticipated for some time, but whichhas now produced formal contracts and which is poised to translate intomeaningful revenues." ENQUIRIES: Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director Pelham Public RelationsArchie Berens Tel. +44 (0)20 7743 6679Kate Catchpole Tel. +44 (0)20 7743 6678KBC Peel Hunt Tel: +44 (0)207 418 8900Julian BluntGordon Suggett About Intercede Intercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). Intercede's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, biometrics, digital certificates and Open Platformapplets. Intercede works with a number of market leading OEM, re-seller and technologypartners that supply MyID technology including: Athena Smartcard Solutions,Gemalto, Oberthur Card Systems, RSA Security, SafeNet, Thales, VeriSign and avariety of systems integrators and other security product and service providers. Intercede and MyID are registered trademarks or trademarks in the UK, US and/orother countries. For more information visit http://www.intercede.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.